Bellon Christine 4
4 · Beam Therapeutics Inc. · Filed Oct 3, 2025
Insider Transaction Report
Form 4
Bellon Christine
Chief Legal Officer
Transactions
- Sale
Common Stock
2025-10-01$24.53/sh−373$9,150→ 116,921 total
Footnotes (1)
- [F1]These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. 2019 Equity Incentive Plan on September 30, 2021. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023.